Vepafestinib

DB18779ExperimentalSmall molecule

Vepafestinib: Overview.

Mechanism: Pharmacologically active on Proto-oncogene tyrosine-protein kinase receptor Ret
Curator reviewed
Formula / weight: C₂₆H₃₀N₆O₃ · 474.565 g/mol (avg)

Resolves to

Compound

Structure

InChIKeySFXVRNLGOSAWIV-UHFFFAOYSA-NSMILESCOCC1=CC=C(NC(=O)C2=C(C#CCN3CCOCC3)N(C3=NC=NC(N)=C23)C2(C)CC2)C=C1

Targets

What you can answer from here — as of July 29, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Vepafestinib, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.